Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Degrell

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Current Drug Targets|July 24, 2004
The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactionsR Berecz, P Dorado, A De La Rubia, et al.
Pharmacopsychiatry|January 9, 2003
Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patientsR Berecz, A LLerena, A de la Rubia, et al.
Actas Espanolas De Psiquiatria|December 19, 2002
[Relationship between clozapine plasma levels and withdrawal symptoms]R Berecz, A de la Rubia Martínez, M J Norberto Gamero, et al.
Orvosi Hetilap|February 2, 1997
[First Hungarian experiences with positron emission tomography (PET) studies. Members of the PET working group]L Trón, O Esik, K Borbély, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Current Drug Targets|July 24, 2004
The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactionsR Berecz, P Dorado, A De La Rubia, et al.
Pharmacopsychiatry|January 9, 2003
Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patientsR Berecz, A LLerena, A de la Rubia, et al.
Actas Espanolas De Psiquiatria|December 19, 2002
[Relationship between clozapine plasma levels and withdrawal symptoms]R Berecz, A de la Rubia Martínez, M J Norberto Gamero, et al.
Orvosi Hetilap|February 2, 1997
[First Hungarian experiences with positron emission tomography (PET) studies. Members of the PET working group]L Trón, O Esik, K Borbély, et al.
Pageof 5